Publicaties Nefrologie 2014 Pagina

Transcription

1 Publicaties Nefrologie 2014 Pagina Abbasi A, Stolk RP, Bakker SJL. Identification of relevant biomarkers for type 2 diabetes. Lancet Diabetes Endocrinol. 2014;2: Abbasi A, Corpeleijn E, Gansevoort RT, Gans ROB, Struck J, Schulte J, Hillege HL, Harst P van der, Stolk RP, Navis GJ, Bakker SJL. Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study. Diabetologia. 2014;57: Abbasi A, Deetman PE, Corpeleijn E, Gansevoort RT, Gans ROB, Hillege HL, Harst P van der, Stolk RP, Navis GJ, Alizadeh BZ, Bakker SJL. Bilirubin as a potential causal factor in type 2 diabetes risk: a Mendelian randomization study. Diabetes 2014;Nov 3. [Epub] 4. Abbasi A, Stolk RP, Bakker SJL. Comment on Vassy et al. Polygenic type 2 diabetes prediction at the limit of common variant detection. Diabetes 2014;63: Diabetes. 2014;63:e Abdelmalek JA, Gansevoort RT, Lambers Heerspink HJ, Ix JH, Rifkin DE. Estimated albumin excretion rate versus urine albumin-creatinine ratio for the assessment of albuminuria: a diagnostic test study from the Prevention of Renal and Vascular Endstage Disease (PREVEND) Study. Am J Kidney Dis. 2014;63: Adema AY, Borst MH de, Wee PM ter, Vervloet MG; NIGRAM Consortium including Sanders JSF, Bakker SJL, Navis GJ. Dietaryand pharmacological modification of fibroblast growth factor-23 in chronic kidney disease. J Ren Nutr. 2014;24: Adepu S, Katta K, Tietge UJ, Kwakernaak AJ, Dam W, Goor H van, Dullaart RPF, Navis GJ, Bakker SJL, Born J van den. Hepatic syndecan-1 changes associate with dyslipidemia after renal transplantation. Am J Transplant. 2014;14: Agterhuis DE, Mulder AH, Roozendaal C, Stegeman CA, Laverman GD. A false-positive antineutrophil cytoplasmic antibody proteinase 3 test in a patient with pulmonary-renal syndrome. J Rheumatol. 2014;41: Alkhalaf A, Landman GW, Hateren KJ van, Groenier KH, Mooyaart AL, Heer E de, Gans ROB, Navis GJ, Bakker SJL, Kleefstra N, Bilo HJ. Sex specific association between carnosinase gene CNDP1 and cardiovascular mortality in patients with type 2 diabetes (ZODIAC-22). J Nephrol. 2014;Apr 23. [Epub] 10. Angelantonio Di E, Gao P, Khan H, Butterworth AS, Wormser D, Kaptoge S et al, including Bakker SJL. Emerging Risk Factors Collaboration. Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA 2014;311: Arends S, Berden JHM, Grootscholten C, Derksen RH, Berger SP, Sévaux RG de, Voskuyl AE, Bijl M; Dutch Working Party on SLE.Arking DE, Pulit SL, Crotti L, Harst P van der, Munroe PB, Koopmann TT et al; Consortium; COGENT Consortium, DCCT/EDIC, emerge Consortium, HRGEN Consortium including Navis GJ et al. Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization. Nat Genet. 2014;46: Arends S, Berden JHm, Grootscholten C, Derksen RH, Berger SP, Sévaux RG de, Voskuyl AE, Bijl M; Dutch Working Party on SLE. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis. Neth J Med. 2014;72: Aslan A, Jongman RM, Moser J, Stegeman CA, Goor H van, Diepstra A, Heuvel MC van den, Heeringa P, Molema G, Zijlstra JG, Meurs M van. The renal angiopoietin/tie2 system in lethal human sepsis. Crit Care. 2014;18: Assa S, Hummel YM, Voors AA, Kuipers J, Westerhuis R, Groen H, Bakker SJL, Muller Kobold AC, Oeveren W van, Struck J, Jong PE de, Franssen CFM. Hemodialysis-induced regional left ventricular systolic dysfunction and inflammation: a cross-sectional study. Am J Kidney Dis. 2014;64: Athanasiou Y, Zavros M, Arsali M, Papazachariou L, Demosthenous P, Savva I, Voskarides K, On Behalf Of The MAURO Working Group, Trujillano D, Bullich G, Ballarin J, Torra R, Estivill X,

2 Publicaties Nefrologie 2014 Pagina Ars E et al, including Borst MH de, Navis GJ. Genetic diseases and molecular genetics. Nephrol Dial Transplant. 2014;29 Suppl 3:iii339-iii Baia LC, Berg E van den, Vervloet MG, Heilberg IP, Navis GJ, Bakker SJL, Geleijnse JM, Kromhout D, Soedamah-Muthu SS, Borst MH de; on behalf of the NIGRAM consortium. Fish and omega-3 fatty acid intake in relation to circulating fibroblast growth factor 23 levels in renal transplant recipients. Nutr Metab Cardiovasc Dis. 2014;24: Berg E van den, Pasch A, Westendorp WH, Navis GJ, Brink EJ, Gans ROB, Goor H van, Bakker SJL. Urinary sulfur metabolites associate with a favorable cardiovascular risk profile and survival benefit in renal transplant recipients. J Am Soc Nephrol. 2014;25: Boer YS de, Gerven NM van, Zwiers A, Verwer BJ, Hoek B van, Erpecum KJ van, Beuers U et al; Dutch Autoimmune Hepatitis Study Group; LifeLines Cohort Study; Study of Health in Pomerania including collaborators including Navis GJ. Genome-wide association study identifies variants associated with autoimmune hepatitis type 1. Gastroenterology. 2014;147: Boersema M, Born JC van den, Ark J van, Harms G, Seelen MAJ, Dijk MC van, Goor H van, Navis GJ, Popa ER, Hillebrands JL. CD16(+) monocytes with smooth muscle cell characteristics are reduced in human renal chronic transplant dysfunction. Immunobiology. 2014;pii:S (14) Bolton JL, Hayward C, Direk N, Lewis JG, Hammond GL, Hill LA et al, including Bakker SJL; CORtisol NETwork (CORNET) Consortium. Genome wide association identifies common variants at the SERPINA6/SERPINA1 locus influencing plasma cortisol and corticosteroid binding globulin. PLoS Genet. 2014;10:e Braam B, Joles JA, Danishwar AH, Gaillard CAJM. Cardiorenal syndrome--current understanding and future perspectives. Nat Rev Nephrol. 2014;10: Broekman KE, Sinkeler SJ, Waanders F, Bartels GL, Navis GJ, Janssen WM. Volume control in treatment-resistant congestive heart failure: role for peritoneal dialysis. Heart Fail Rev. 2014;19: Brouwers FP, Gilst WH van, Damman K, Berg M van den, Gansevoort RT, Bakker SJL, Hillege HL, Veldhuisen DJ van, Harst P van der, Boer RA de. Clinical risk stratification optimizes value of biomarkers to predict new onset heart failure in a community-based cohort. Circ Heart Fail. 2014;7: Cabrera-López C, Ars E, Marti T, Harris PC, Torra R, Clerckx C et al including Gansevoort RT, Bakker SJL, Gaillard CAJM. Renal development and cystic diseases. Nephrol Dial Transplant. 2014;29 Suppl 3:iii73-iii Casteleijn NF, Jager RL de, Neeleman MP, Blankestijn PJ, Gansevoort RT. Chronic kidney pain in autosomal dominant polycystic kidney disease: a case report of successful treatment by catheter-based renal denervation. Am J Kidney Dis. 2014;63: Casteleijn NF, Spithoven EM, Rookmaaker MB, Vergouwen MD, Gansevoort RT. Bilateral cysts in the choroid plexus in a patient with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2014; Aug 7. [Epub] 27. Casteleijn NF, Visser FW, Drenth JP, Gevers TJ, Groen GJ, Hogan MC, Gansevoort RT; DIPAK Consortium. A stepwise approach for effective management of chronic pain in autosomal-dominant polycystic kidney disease. Nephrol Dial Transplant. 2014;29 Suppl 4:iv Casteleijn NF, Blankestijn PJ, Gansevoort RT. In reply to 'catheter-based renal denervation in ADPKD: just for pain control?'. Am J Kidney Dis. 2014;64: CLOTS (Clots in Legs Or stockings after Stroke) Trials collaboration including Navis GJ et al. Effect of intermittent pneumatic compression on disability, living circumstances, quality of life, and hospital costs after stroke: secondary analyses from CLOTS 3, a randomised trial. Lancet Neurol. 2014;13:

3 Publicaties Nefrologie 2014 Pagina Cornec-Le Gall E, Hourmant M, Morin MP, Charasse C, Renaudineau E, Wehbe B et al; GENKYST Study Group, Audrézet MP, Férec C, Le Meur Y, Spithoven EM, Meijer E, Borns C, Boertien WE, Kappert P, Greuter MJ, Jagt E van der, Jong PE de, Gaillard CAJM, Gansevoort RT et al. Adpkd - clinical outcome studies. Nephrol Dial Transplant. 2014;29 Suppl 3:iii5-iii6 31. Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ et al, including Jong PE de, Gansevoort RT, Bakker SJL; for the CKD Prognosis Consortium. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014;311: Cornelis T, Tennankore KK, Goffin E, Rauta V, Honkanen E, Ozyilmaz A, Thanaraj V, Jayanti A, Mitra S, van der Sande FM, Kooman JP, Chan CT. An international feasibility study of home haemodialysis in older patients. Nephrol Dial Transplant. 2014;29: Corsetti JP, Gansevoort RT, Bakker SJL, Sparks CE, Vart P, Dullaart RPF. Apolipoprotein B attenuates albuminuria-associated cardiovascular disease in Prevention of Renal and Vascular Endstage Disease (PREVEND) Participants. J Am Soc Nephrol. 2014;25: Damman J, Bloks VW, Daha MR, Most P van der, Sanjabi B, Vlies P van der, Snieder H, Ploeg RJ, Krikke C, Leuvenink HG, Seelen MAJ. Hypoxia and complement-and-coagulation pathways in the deceased organ donor as the major target for intervention to improve renal allograft outcome. Transplantation. 2014;Nov 25. [Epub] 35. Deetman PE, Bakker SJL, Kwakernaak AJ, Navis GJ, Dullaart RPF; PREVEND Study Group, including collaborators Jong PE de, Gansevoot RT et al. The relationship of the anti-oxidant bilirubin with free thyroxine is modified by insulin resistance in euthyroid subjects. PLoS One. 2014;9:e Deetman PE, Said MY, Kromhout D, Dullaart RPF, Kootstra-Ros JE, Sanders JSF, Seelen MAJ, Gans ROB, Navis GJ, Joosten MM, Bakker SJL. Urinary urea excretion and long-term outcome after renal transplantation. Transplantation. 2014;Nov 12. [Epub] 37. Devuyst O, Knoers NV, Remuzzi G, Schaefer F; Board of the Working Group for Inherited Kidney Diseases of the European Renal Association and European Dialysis and Transplant Association, including collaborators Antignac C, Bindels R, Chauveau D, Devuyst O, Emma F, Gansevoort RT et al. Rare inherited kidney diseases: challenges,opportunities, and perspectives. Lancet. 2014;383: Doesum WB van, Abdulahad WH, Dijk MC van, Dolff S, Son WJ van, Stegeman CA, Sanders JSF. Characterization of urinary CD4(+) and CD8(+) T cells in kidney transplantation patients with polyomavirus BK infection and allograft rejection. Transpl Infect Dis. 2014;16: Dontje ML, Greef MH de, Krijnen WP, Corpeleijn E, Kok T, Bakker SJL, Stolk RP, Schans CP van der. Longitudinal measurement of physical activity following kidney transplantation. Clin Transplant. 2014;28: Dullaart RPF, Boersema J, Lefrandt JD, Wolffenbuttel BHR, Bakker SJL. The inverse association of incident cardiovascular disease with plasma bilirubin is unaffected by adiponectin. Atherosclerosis. 2014;235: Dullaart RPF, Haperen R van, Born J van den, Goor H van, Crom R de, Tol A van. No renal phenotype in human phospholipid transfer protein transgenic apolipoprotein E deficient mice despite severe aortic atherosclerosis. Clin Lab 2014:60:1659: Dijkstra AE, Smolonska J, Berge M van den, Wijmenga C, Zanen P, Luinge MA et al. LifeLines Cohort study including collaborators Navis GJ et al. Susceptibility to chronic mucus hypersecretion, a genome wide association study. PLoS One. 2014;9:e Emerging Risk Factors Collaboration, Di Angelantonio E, Gao P, Khan H,Butterworth AS, Wormser D, Kaptoge S, Kondapally Seshasai SR, Bakker SJL et al. Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA. 2014;26;311: Engel MF, Bruns AH, Hulscher ME, Gaillard CAJM, Sankatsing SU, Teding van Berkhout F, Emmelot-Vonk MH, Kuck EM, Steeghs MH, Breeijen JH den, Stellato RK, Hoepelman AI, Oosterheert JJ. A tailored implementation strategy to reduce the duration of intravenous

4 Publicaties Nefrologie 2014 Pagina antibiotic treatment in community-acquired pneumonia: a controlled before-and-after study. Eur J Clin Microbiol Infect Dis. 2014;33: Eny KM, Lutgers HL, Maynard J, Klein BE, Lee KE, Atzmon G, Monnier VM, Vliet-Ostaptchouk JV van, Graaff R, Harst P van der, Snieder H, Klauw MM van der, Sell DR, Hosseini SM, Cleary PA, Braffett BH, Orchard TJ, Lyons TJ, Howard K, Klein R, Crandall JP, Barzilai N, Milman S, Ben-Avraham D; LifeLines Cohort Study Group; DCCT/EDIC Research Group; coloborators including Navis GJ et al. GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence. Diabetologia 2014;57: Ettema EM, Zittema D, Kuipers J, Gansevoort RT, Vart P, Jong PE de, Westerhuis R, Franssen CFM. Dialysis Hypotension: A role for inadequate increase in arginine Vasopressin levels? A Systematic Literature Review and Meta-Analysis. Am J Nephrol. 2014;39: Faria B, Henriques C, Matos AC, Daha MR, Pestana M, Seelen MAJ. Combined C4d and CD3 immunostaining predicts IgA nephropathy progression. Clin Exp Immunol. 2014;Sep 30. [Epub] 48. Ganesh SK, Chasman DI, Larson MG, Guo X, Verwoert G, Bis JC, GU X et al, including collaborators Jong PE de, Navis GJ et al. Effects of long-term averaging of quantitative blood pressure traits on the detection of genetic associations. Am J Hum Genet. 2014;3:95: Gastel MD van, Meijer E, Scheven LE, Struck J, Bakker SJL, Gansevoort RT. Modifiable factors associated with copeptin concentration: A general population cohort. Am J Kidney Dis. 2014; Oct 31. [Epub] 50. Gelder T van, Berden JH, Berger SP. To TDM or not to TDM in lupus nephritis patients treated with MMF? Nephrol Dial Transplant. 2014;May 8. [Epub] 51. Gerrits EG, Alkhalaf A, Landman GW, Hateren KJ van, Groenier KH, Struck J, Schulte J, Gans ROB, Bakker SJL, Kleefstra N, Bilo HJ. Serum peroxiredoxin 4: a marker of oxidative stress associated with mortality in type 2 diabetes (ZODIAC-28). PLoS One. 2014;9:e Gieteling E, Leur JJ van de, Stegeman CA, Groeneveld PH. Accurate and fast diagnostic algorithm for febrile urinary tract infections in humans. Neth J Med. 2014;72: Gorski M, Tin A, Garnaas M, McMahon GM, Chu AY, Tayo BO et al including Bakker SJL, Gansevoort RT et al. Genome-wide association study of kidney function decline in individuals of European descent. Kidney Int. 2014;Dec 10. [Epub] 54. Hallan SI, Gansevoort RT. Should we diagnose CKD using the 'one-size fits all' KDIGO 2012 guideline or do we need a more complex age-specific classification system? Nephrol Dial Transplant. 2014;Jan 20. [Epub] 55. Hoggart CJ, Venturini G, Mangino M, Gomez F, Ascari G, Zhao JH et al; Generation Scotland Consortium; LifeLines Cohort study, Colloborators including Navis GJ; GIANT Consortium, Novel approach identifies SNPs in SLC2A10 and KCNK9 with evidence for parent-of-origin effect on body mass index. PLoS Genet. 2014;1;10(7) 56. Hu N, Mora-Jensen H, Theilgaard-Mönch K, Doornbos-van der Meer B, Huitema MG, Stegeman CA, Heeringa P, Kallenberg CGM, Westra J. Differential expression of granulopoiesis related genes in neutrophil subsets distinguished by membrane expression of CD177. PLoS One. 2014;13;9:e Huang Y, Caputo CR, Noordmans GA, Yazdani S, Monteiro LH, Born J van den, van Goor H, Heeringa P, Korstanje R, Hillebrands JL. Identification of novel genes associated with renal tertiary lymphoid organ formation in aging mice. PLoS One. 2014;17;9:e Huang J, Huffman JE, Yamkauchi M, Trompet S, Asselbergs FW, Sabater-Lleal M et al including Navis GJ. Cohorts for Heart and Aging Research in Genome Epidemiology (CHARGE) Consortium Neurology Working Group; CARDIoGRAM Consortium; Consortium Hemostatic Factor Working Group. Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2. Arterioscler Thromb Vasc Biol. 2014;34:

5 Publicaties Nefrologie 2014 Pagina Humalda JK, Assa S, Navis GJ, Franssen CFM, Borst MH de, Ogawa H et al including Gansevoort RT, Bakker SJL, Gaillard CAJM, Westerhuis R, Franssen CFM. Dialysis. Pathophysiology and clinical studies. Nephrol Dial Transplant. 2014;29 Suppl 3:iii501-iii Humalda JK, Navis GJ. Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney disease. Curr Opin Nephrol Hypertens. 2014;23: Huzen J, Wong LS, Veldhuisen DJ van, Samani NJ, Zwinderman AH, Codd V, Cawthon RM, Benus GF, Horst IC van der, Navis GJ, Bakker SJL, Gansevoort RT, Jong PE de, Hillege HL, Gilst WH van, Boer RA de, Harst P van der. Telomere length loss due to smoking and metabolic traits. J Intern Med. 2014;275: Ipema KJ, Westerhuis R, Schans CP van der, Jong PE de, Gaillard CAJM, Krijnen WP, Slart RH, Franssen CFM. Effect of nocturnal haemodialysis on body composition. Nephron Clin Pract. 2014; 2014;128: Jayakumar C, Nauta FL, Bakker SJL, Bilo H, Gansevoort RT, Johnson MH, Ramesh G. Netrin- 1, a urinary proximal tubular injury marker, is elevated early in the time course of human diabetes. J Nephrol. 2014;27: Jong K de, Boezen HM, Kromhout H, Vermeulen R, Postma DS, Vonk JM,; LifeLines Cohort Study, including collaborators Navis GJ et al. Pesticides and other occupational exposures are associated with airway obstruction: the LifeLines cohort study. Occup Environ Med 2014:71: Jong K de, Vonk JM, Kromhout H, Vermeulen R, Postma DS, Boezen HM; LifeLines Cohort Study, including collaborators Navis GJ et al. NOS1: a susceptibility gene for reduced level of FEV1 in the setting of pesticide exposure. Am J Respir Crit Care Med. 2014;v15;190: Joode AAE de, Sanders JSF, Smid MW, Stegeman CA. Plasmapheresis rescue therapy in progressive systemic ANCA-associated vasculitis: Single-center results of stepwise escalation of immunosuppression. J Clin Apher. 2014;29: Joode AAE de, Roozendaal C, Leij MJ van der, Bungener LB, Sanders JSF, Stegeman CA. Performance of two strategies for urgent ANCA and anti-gbm analysis in vasculitis. Eur J Intern Med. 2014;25: Joosten H, Visser ST, Eersel ME van, Gansevoort RT, Bilo HJ, Slaets JP, Izaks GJ. Statin use and cognitive function: population-based observational study with long-term follow-up. PLoS One. 2014;9:e Joosten MM, Gansevoort RT, Mukamal KJ, Lambers Heerspink HJ, Geleijnse JM, Feskens EJ, Navis GJ, Bakker SJL; PREVEND Study Group. Sodium excretion and risk of developing coronary heart disease. Circulation 2014;129: Joosten MM, Pai JK, Bertoia ML, Gansevoort RT, Bakker SJL, Cooke JP, Rimm EB, Mukamal KJ. β2-microglobulin, cystatin C, and creatinine and risk of symptomatic peripheral artery disease. J Am Heart Assoc. 2014;3(4) 71. Kallenberg CGM, Stegeman CA, Abdulahad WH, Heeringa P. In Reply to 'Rituximab and B-Cell Return in ANCA-Associated Vasculitis'. Am J Kidney Dis. 2014;63: Keyzer CA, Riphagen IJ, Joosten MM, Navis GJ, Muller Kobold AC, Kema IP, Bakker SJL, Borst MH de. Associations of 25(OH) and 1,25(OH)(2) Vitamin D with Long-Term Outcomes in Stable Renal Transplant Recipients. J Clin Endocrinol Metab. 2014;Oct 31. [Epub] 73. Kieneker LM, Gansevoort RT, Mukamal KJ, Boer RA de, Navis GJ, Bakker SJL, Joosten MM. Urinary potassium excretion and risk of developing hypertension: The prevention of renal and vascular end-stage disease study. Hypertension. 2014;64: Kurnatowska I, Grzelak P, Masajtis-Zagajewska A, Kaczmarska M, Stefańczyk L,Vermeer C et al including Navis GJ; On Behalf Of Mauro Working Group. Ckd pathophysiology and clinical studies. Transplant. 2014;29 Suppl 3:iii148-iii Kwakernaak AJ, Krikken JA, Binnenmars SH, Visser FW, Hemmelder MH, Woittiez AJ, Groen H, Laverman GD, Navis GJ; Holland Nephrology study (HONEST) group including collaborators Borst MH de et al. Effects of sodium restriction and hydrochlorothiazide on RAAS blockade

6 Publicaties Nefrologie 2014 Pagina efficacy in diabetic nephropathy: a randomised clinical trial. Lancet Diabetes Endocrinol. 2014;2: Lambers Heerspink HJ, Weldegiorgis M, Inker LA, Gansevoort RT, Parving HH, Dwyer JP, Mondal H, Coresh J, Greene T, Levey AS, Zeeuw D de. Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the reduction of end points in non-insulindependent diabetes with the angiotensin II antagonist losartan (RENAAL) study and Irbesartan Diabetic Nephropathy Trial (IDNT). Am J Kidney Dis. 2014;63: Lambers Heerspink HJ, Gaillard CAJM, Gansevoort RT. Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease. Ann Intern Med. 2014;161: Landman GW, van Dijk PR, Drion I, van Hateren KJ, Struck J, Groenier KH, Gans ROB, Bilo HJ, Bakker SJL, Kleefstra N. Midregional fragment of pro-adrenomedullin, new-onset albuminuria, and cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-30). Diabetes Care. 2014;37: Laville M, Dorval M, Fort Ros J, Fay R, Cridlig J, Nortier JL, Juillard L, Dębska-Ślizień A, Fernández Lorente L, Thibaudin D, Franssen CFM, Schulz M, Moureau F, Loughraieb N, Rossignol P. Results of the HepZero study comparing heparin-grafted membrane and standard care show that heparin-grafted dialyzer is safe and easy to use for heparin-free dialysis. Kidney Int. 2014;86: Lepse N, Abdulahad WH, Rutgers A, Kallenberg CGM, Stegeman CA, Heeringa P. Altered B cell balance, but unaffected B cell capacity to limit monocyte activation in anti-neutrophil cytoplasmic antibody-associated vasculitis in remission. Rheumatology (Oxford). 2014;53: Li N, van der Sijde MR, Study LC, Bakker SJL, Dullaart RPF, Harst P van der, Gansevoort RT, Elbers CC, Wijmenga C, Snieder H, Hofker MH, Fu J. Pleiotropic effects of lipid genes on plasma glucose, HbA1c and HOMA-IR levels. Diabetes. 2014;63: Lintermans LL, Stegeman CA, Heeringa P, Abdulahad WH. T cells in vascular inflammatory diseases. Front Immunol. 2014;5:504 ecollection 2014;5:14 [Review] 83. Londen M van, Humalda JK, Aarts BM, Sanders JSF, Bakker SJL, Navis GJ, Borst MH de et al. Transplantation clinical 2. Nephrol Dial Transplant. 2014;29 Suppl 3:iii539-iii Maaten JM ter, Damman K, Hillege HL, Bakker SJL, Anker SD, Navis GJ, Voors AA. Creatinine excretion rate, a marker of muscle mass, is related to clinical outcome in patients with chronic systolic heart failure. Clin Res Cardiol. 2014; Macdougall IC, Bock AH, Carrera F, Eckardt KU, Gaillard CAJM, Wyck D van, Roubert B, Nolen JG, Roger SD; on behalf of the FIND-CKD Study Investigators. FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia. Nephrol Dial Transplant. 2014;Jun 2. pii: gfu201. [Epub] 86. Mahmoodi BK, Yatsuya H, Matsushita K, Sang Y, Gottesman RF, Astor BC, Woodward M, Longstreth WT Jr, Psaty BM, Shlipak MG, Folsom AR, Gansevoort RT, Coresh J. Association of Kidney Disease Measures With Ischemic Versus Hemorrhagic Strokes: Pooled Analyses of 4 Prospective Community-Based Cohorts. Stroke. 2014;45: Meuleman Y, Brinke L ten, Kwakernaak AJ, Vogt L, Rotmans JI, Bos WJ, Boog PJ van der, Navis GJ, Montfrans GA van, Hoekstra T, Dekker FW, Dijk S van. Perceived barriers and support strategies for reducing sodium intake in patients with chronic kidney disease: a qualitative study. Int J Behav Med. 2014;Oct 9. [Epub] 88. Meijer E, Drenth JP, d'agnolo H, Casteleijn NF, Fijter JW de, Gevers TJ,Kappert P, Peters DJ, Salih M, Soonawala D, Spithoven EM, Torres VE, Visser FW, Wetzels JF, Zietse R, Gansevoort RT; DIPAK Consortium. Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2014;63: Meijers B, Glorieux G, Poesen R, Bakker SJL. Nonextracorporeal methods for decreasing uremic solute concentration: a future way to go? Semin Nephrol. 2014;34:228-43

7 Publicaties Nefrologie 2014 Pagina Meijers WC, Velde AR van der, Ruifrok WP, Schroten NF, Dokter MM, Damman K, Assa S, Franssen CFM, Gansevoort RT, Gilst WH van, Silljé HH, de Boer RA. Renal handling of galectin-3 in the general population, chronic heart failure, and hemodialysis. J Am Heart Assoc. 2014;18;3:e Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA et al, including Stegeman CA. Rituximab for the treatment of relapses in ANCA-associated vasculitis. Arthritis Rheumatol. 2014;Jul 21. [Epub] 92. Meijers B, Glorieux G, Poesen R, Bakker SJL. Nonextracorporeal methods for decreasing uremic solute concentration: a future way to go? Semin Nephrol. 2014;34: Meyer S, Brouwers FP, Voors AA, Hillege HL, de Boer RA, Gansevoort RT, Harst P van der, Rienstra M, van Gelder IC, Veldhuisen DJ van, Gilst WH van, Meer P van der. Sex differences in new-onset heart failure. Clin Res Cardiol. 2014;Nov 15. [Epub] 94. Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA et al including Stegeman CA. Rituximab in ANCA-associated Vasculitis-Immune Tolerance Network Research Group. Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol. 2014;66: Moes DJ, Swen JJ, den Hartigh J, Straaten T van der, Homan van der Heide JJ, Sanders JSF, Bemelman FJ, de Fijter JW, Guchelaar HJ. Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on cyclosporine, everolimus, and tacrolimus pharmacokinetics in renal transplantation. CPT Pharmacometrics Syst Pharmacol. 2014;3:e Mohamed R, Ranganathan P, Jayakumar C, Nauta FL, Gansevoort RT, Weintraub NL, Brands M, Ramesh G. Urinary semaphorin 3A correlates with diabetic proteinuria and mediates diabetic nephropathy and associated inflammation in mice. J Mol Med (Berl). 2014;92: Nacak H, Diepen M van, Goeij MC de, Rotmans JI, Dekker FW; including collaborators Franssen CFM et al. PREPARE-2 study Uric acid: association with rate of renal function decline and time until start of dialysis in incident pre-dialysis patients. BMC Nephrol. 2014;16;15: Navis GJ, Blankestijn PJ, Deegens J, De Fijter JW, Homan van der Heide JJ, Rabelink T, Krediet RT, Kwakernaak AJ, Laverman GD, Leunissen KM, Paassen P van, Vervloet MG, Wee PM, Wetzels JF, Zietse R, van Ittersum FJ; on behalf of the BIND-NL investigators. The Biobank of nephrological diseases in the Netherlands cohort: the string of pearls initiative collaboration on chronic kidney disease in the university medical centers in the Netherlands. Nephrol Dial Transplant. 2014;29: Otten HG, Joosten I, Allebes WA, Meer A van der, Hilbrands LB, Baas M et al, including Seelen MAJ, Sanders JSF. The PROCARE consortium: Toward an improved allocationstrategy for kidney allografts. Transpl Immunol. 2014;31: Oude Voshaar RC, Derks WJ, Comijs HC, Schoevers RA, Borst MH de, Marijnissen RM. Antidepressants differentially related to 1,25-(OH)₂ vitamin D₃ and 25-(OH) vitamin D₃ in late-life depression. Transl Psychiatry. 2014;4:e Pena MJ, Lambers Heerspink HJ, Hellemons ME, Friedrich T, Dallmann G, Lajer M, Bakker SJL, Gansevoort RT, Rossing P, Zeeuw D de, Roscioni SS. Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus. Diabet Med. 2014;31: Pennells L, Kaptoge S, White IR, Thompson SG, Wood AM; Emerging Risk Factors Collaboration including collaborators Gansevoort RT, Bakker SJL. Assessing risk prediction models using individual participant data from multiple studies. Am J Epidemiol. 2014;179: Perry JR, Day F, Elks CE, Sulem P, Thompson DJ, Ferreira T, He C et al. Australian Ovarian Cancer Study; GENICA Network; kconfab; LifeLines Cohort Study including Navis GJ et al. InterAct Consortium; Early Growth Genetics (EGG) Consortium, Boomsma DI, Econs MJ, Khaw KT, Loos RJ, McCarthy MI, Montgomery GW, Rice JP, Ong KK. Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. Nature. 2014;2:514:92-7

8 Publicaties Nefrologie 2014 Pagina Petzold K, Gansevoort RT, Ong AC, Devuyst O, Rotar L, Eckardt KU, Köttgen A,Pirson Y, Remuzzi G, Sandford R, Tesar V, Ecder T, Chaveau D, Torra R, Budde K,Le Meur Y, Wüthrich RP, Serra AL. Building a network of ADPKD reference centres across Europe: the EuroCYST initiative. Nephrol Dial Transplant. 2014;Suppl 4:iv26-32 Erratum in: Nephrol Dial Transplant. 2014;29: Riese H, Muñoz LM, Hartman CA, Ding X, Su S, Oldehinkel AJ, Roon AM van, Most PJ van der, Lefrandt J, Gansevoort RT, Harst P van der, Verweij N, Licht CM,Boomsma DI, Hottenga JJ, Willemsen G, Penninx BW, Nolte IM, Geus EJ de, Wang X, Snieder H. Identifying genetic variants for heart rate variability in the acetylcholine pathway. PLoS One. 2014;10;9:e Riphagen IJ, Deetman PE, Bakker SJL, Navis GJ, Cooper ME, Lewis JB, Zeeuw D de, Lambers Heerspink HJ. Bilirubin and progression of nephropathy in type 2 diabetes: A post-hoc analysis of RENAAL with independent replication in IDNT. Diabetes. 2014; Rocco M, Daugirdas J, Greene T, Lockridge R, Chan C, Pierratos A et al; FHN Trial Group, Laville M,Dorval M, Fort Ros J, Fay R, Cridlig J, Nortier JL et al including Franssen CFM. New dialysistechniques. Nephrol Dial Transplant. 2014;29 Suppl 3:iii37-iii Roger SD, Bock A, Carrera F, Eckardt KU, Gaillard CAJM, Wyck D van et al. Ckd anaemia. Nephrol Dial Transplant. 2014;29 Suppl 3:iii21-iii Rosmalen JG, Kema IP, Wüst S, van der Ley C, Visser ST, Snieder H, Bakker SJL. 24 h urinary free cortisol in large-scale epidemiological studies: short-term and long-term stability and sources of variability. Psychoneuroendocrinology. 2014;47: Ruilope LM, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, Remuzzi G,Rossing P, Schmieder RE, Nowack C, Ferreira AC, Pieper A, Kimmeskamp-Kirschbaum N, Bakris GL. Rationale, Design, and baseline characteristics of ARTS-DN: A Randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy. Am J Nephrol. 2014;40: Sanders JSF, Abdulahad WH, Stegeman CA, Kallenberg CGM. Pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis and potential targets for biologic treatment. Nephron Clin Pract. 2014;128: Sharif A, Hecking M, Vries AP de, Porrini E, Hornum M, Rasoul-Rockenschaub S, Berlakovich G, Krebs M, Kautzky-Willer A, Schernthaner G, Marchetti P, Pacini G, Ojo A, Takahara S, Larsen JL, Budde K, Eller K, Pascual J, Jardine A, Bakker SJL, Valderhaug TG, Jenssen TG, Cohney S, Säemann MD. Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am J Transplant. 2014;14: Scheven L, Joosten MM, Jong PE de, Bakker SJL, Gansevoort RT; PREVEND study group. The association of albuminuria with tubular reabsorption of uric acid: results from a general population cohort. J Am Heart Assoc. 2014;3:e Schulz T, Niesing J, Homan van der Heide JJ, Westerhuis R, Ploeg RJ, Ranchor AV. Great expectations? Pre-transplant quality of life expectations and distress after kidney transplantation: a prospective study. Br J Health Psychol. 2014;19: Shaffi K, Uhlig K, Perrone RD, Ruthazer R, Rule A, Lieske JC, Navis GJ, Poggio ED, Inker LA, Levey AS. Performance of creatinine-based GFR estimating equations in solid-organ transplant recipients. Am J Kidney Dis. 2014;63: Sidorenkov G, Navis GJ. Safety of ACE inhibitor therapies in patients with chronic kidney disease. Expert Opin Drug Saf. 2014;13: Simino J, Shi G, Bis JC, Chasman DI, Ehret GB, Gu X et al; LifeLines Cohort Study including Navis GJ et al. Gene-age interactions in blood pressure regulation: a large-scale investigation with the CHARGE, Global BPgen, and ICBP consortia. Am J Hum Genet. 2014;3;95: Siwy J, Schanstra JP, Argiles A, Bakker SJL, Beige J, Boucek P et al including Navis GJ. Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy. Nephrol Dial Transplant. 2014;1563:70

9 Publicaties Nefrologie 2014 Pagina Smink PA, Miao Y, Eijkemans MJ, Bakker SJL, Raz I, Parving HH, Hoekman J, Grobbee DE, Zeeuw D de, Lambers Heerspink HJ. The importance of short-term off-target effects in estimating the long-ter renal and cardiovascular protection of angiotensin receptor blockers. Clin Pharmacol Ther. 2014;95: Snijder PM, Frenay AR, Koning AM, Bachtler M, Pasch A, Kwakernaak AJ, Berg E van den, Bos EM, Hillebrands JL, Navis GJ, Leuvenink HG, Goor H van. Sodium thiosulfate attenuates angiotensin II-induced hypertension, proteinuria and renal damage. Nitric Oxide. 2014;42: Souza AW de, Leeuw K de, Timmeren MM van, Limburg PC, Stegeman CA, Bijl M, Westra J, Kallenberg CGM. Impact of serum high mobility group box 1 and soluble receptor for advanced glycation end-products on subclinical atherosclerosis in patients with granulomatosis with polyangiitis. PLoS One. 2014;9:e Souza AW de, Abdulahad WH, Sosicka P, Bijzet J, Limburg PC, Stegeman CA, Bijl M, Westra J, Kallenberg CGM. Are urinary levels of high mobility group box 1 markers of active nephritis antineutrophil cytoplasmic antibody - associated vasculitis? Clin Exp Immunol. 2014;178: Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Abad JM, Aresté N, de la Torre RA, Caskey F, Couchoud C, Finne P, Heaf J, Hoitsma A, de Meester J, Pascual J, Postorino M, Ravani P, Zurriaga O, Jager KJ, Gansevoort RT; ERA-EDTA Registry; EuroCYST Consortium; WGIKD. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry. Nephrol Dial Transplant Sep;29 Suppl 4;iv Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Caskey F, Collart F, Finne P, Fogarty DG, Groothoff JW, Hoitsma A, Nogier MB, Postorino M, Ravani P, Zurriaga O, Jager KJ, Gansevoort RT; on behalf of the ERA-EDTA Registry; EuroCYST Consortium; the WGIKD. Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease. Kidney Int. 2014;86: Stamellou E, Storz D, Botov S, Ntasis E, Wedel J, Sollazzo S, Krämer BK, Son WJ van, Seelen MAJ, Schmalz HG, Schmidt A, Hafner M, Yard BA. Different design of enzyme-triggered COreleasing molecules (ET-CORMs) reveals quantitative differences in biological activities in terms of toxicity and inflammation. Redox Biol. 2014;;2: Teunissen-Beekman KF, Dopheide J, Geleijnse JM, Bakker SJL, Brink EJ, Leeuw PW de, Serroyen J, Baak MA van. Differential effects of proteins and carbohydrates on postprandial blood pressure-related responses. Br J Nutr. 2014;112: Tragante V, Barnes MR, Ganesh SK, Lanktree MB, Guo W, Franceschini N et al including Gansevoort RT. Gene-centric meta-analysis in 87,736 individuals of European ancestry identifies multiple blood-pressure-related loci. Am J HumGenet. 2014;94: Turin TC, Matsushita K, Coresh J, Arima H, Chadban SJ, Cirillo M et al including Jong PE de, Gansevoort RT. Ckd epidemiology. Nephrol Dial Transplant. 2014;29 Suppl 3:iii54-iii Turin TC, Ahmed SB, Tonelli M, Manns B, Ravani P, James M, Quinn RR, Jun M, Gansevoort RT, Hemmelgarn B. Kidney function, albuminuria and life expectancy. Can J Kidney Health Dis. 2014;1: Valente MA, Hillege HL, Navis GJ, Voors AA, Dunselman PH, Veldhuisen DJ van, Damman K. The Chronic Kidney Disease Epidemiology Collaboration equation outperforms the modification of diet in renal disease equation for estimating glomerular filtration rate in chronic systolic heart failure. Eur J Heart Fail. 2014;16: Vart P, Bakker SJL, Schöttker B, Zeeuw D de, Rothenbacher D, Brenner H, Heerspink HJ, Saum KU, Reijneveld SA, Bültmann U, Koenig W, Gansevoort RT. Relevance of correction for drift and day-to-day variation in cystatin C measurement: a post-hoc analysis of the PREVEND cohort, with independent replication in the ESTHER cohort. Clin Chem Lab Med. 2014;Nov 21. [Epub]

10 Publicaties Nefrologie 2014 Pagina Verbeek DE, Waanders F, Mulder AB, Bierman WF, Croles FN. Quiz page may 2014: acute kidney injury with red urine. Am J Kidney Dis. 2014;63:A Vimaleswaran KS, Cavadino A, Berry DJ; LifeLines Cohort Study investigators including Navis GJ et al; International Consortium for Blood Pressure (ICBP); Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium; Global Blood Pressure Genetics (Global BPGen) consortium including Borst MH de; Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study. Lancet Diabetes Endocrinol. 2014;2: Volgina G, Gadzhikulieva M, Uyshuk N, Kawamura E, Hisano S, Nakashima H et al including Son WJ van, Sanders JSF. Renal histopathology. Nephrol Dial Transplant. 2014;29 Suppl 3:iii451-iii Voors AA, Dahlke M, Meyer S, Stepinska J, Gottlieb SS, Jones A, Zhang Y,Laurent D, Slart RH, Navis GJ. Renal hemodynamic effects of serelaxin in patients with chronic heart failure: A randomized, Placebo-controlled study. Circ Heart Fail. 2014;7: Vusse ML van der, Son WJ van, Ott A, Manson W. Helicobacter canis bacteremia in a renal transplant patient. Transpl Infect Dis. 2014;16: Walsh M, Faurschou M, Berden A, Flossmann O, Bajema I, Hoglund P et al. European Vasculitis Study Group including collaborators Stegeman CA et al. Long-term follow-up of cyclophosphamide compared with azathioprine for initial maintenance therapy in ANCAassociated vasculitis. Clin J Am Soc Nephrol. 2014;5;9: Wen CP, Matsushita K, Coresh J, Iseki K, Islam M, Katz R, McClellan W, Peralta CA, Wang H, Zeeuw D de, Astor BC, Gansevoort RT, Levey AS, Levin A. Chronic Kidney Disease Prognosis Consortium including collaborators Bakker SJL, Jong PE de et al. Relative risks of chronic kidney disease; for mortality and end-stage renal disease across races are similar. Kidney Int. 2014;86: Winkler TW, Day FR, Croteau-Chonka DC, Wood AR, Locke AE, Mägi R, Ferreira T, Fall T, Graff M, Justice AE, Luan J, Gustafsson S, Randall JC, Vedantam S, Workalemahu T, Kilpeläinen TO, Scherag A, Esko T, Kutalik Z, Heid IM, Loos RJ; Genetic Investigation of Anthropometric Traits (GIANT) Consortium including collaborators Bakker SJL, Navis GJ et al. Quality control and conduct of genome-wide association meta-analyses. Nat Protoc. 2014;9: Wood AR, Esko T, Yang J, Vedantam S, Pers TH, Gustafsson S, et al, including Navis GJ, Gansevoort RT, Bakker SJL. Electronic Medical Records and Genomics (emerge) Consortium; MIGen Consortium; PAGE Consortium; LifeLines Cohort Study. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat Genet. 2014;46: Yazdani S, Navis GJ, Hillebrands JL, Goor H van, Born van den J. Lymphangiogenesis in renal diseases: passive bystander or active participant? Expert Rev Mol Med. 2014;16:e Zaferani A, Talsma D, Richter MK, Daha MR, Navis GJ, Seelen MAJ, Born J van den. Heparin/heparan sulphate interactions with complement--a possible target for reduction of renal function loss? Nephrol Dial Transplant. 2014;29: Zaferani A, Talsma DT, Yazdani S, Celie JW, Aikio M, Heljasvaara R, Navis GJ, Pihlajaniemi T, Born J van den. Basement membrane zone collagens XV and XVIII/proteoglycans mediate leukocyte influx in renal ischemia/reperfusion. PLoS One. 2014;9:e Zittema D, Berg E van den, Meijer E, Boertien WE, Muller Kobold AC, Franssen CFM, Jong PE de, Bakker SJL, Navis GJ, Gansevoort RT. Kidney function and plasma copeptin levels in healthy kidney donors and autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol. 2014;9:

11 Publicaties Nefrologie 2014 Pagina DISSERSATIES Kwakernaak AJ Pathophysiological aspects of lifestyle and the kidney Promtor: prof dr GJ Navis Co-promotores: dr RPF Dullaart, dr MH Hemmelder, dr GD Laverman Rijksuniversiteit Groningen, Faculteit der Medische Wetenschappen Groningen, Boertien WE Vasopressin in chronic kidney disease and its effects in autosomal dominant polycystic kidney disease Promotor: prof dr PE de Jong Co-promotor: dr RT Gansevoort Rijksuniversiteit Groningen, Faculteit der Medische Wetenschappen Groningen, Joosten JMH Defining risk factors associated with renal and cognitive dysfunction Promotores: prof dr HJG Bilo, prof dr JPJ Slaets Co-promotores: dr RT Gansevoort, dr GJ Izaks Rijksuniversiteit Groningen, Faculteit der Medische Wetenschappen Groningen, Assa S Hemodialysis-induced left ventricular dysfunction Promotores: prof dr PE de Jong, prof dr AA Voors Co-promotores: dr CFM Franssen Rijksuniversiteit Groningen, Faculteit der Medische Wetenschappen Groningen, Scheven L Novel aspects regarding mechanisms and consequences of albuminuria Promotor: prof dr PE de Jong Co-promotores: dr RT Gansevoort Rijksuniversiteit Groningen, Faculteit der Medische Wetenschappen Groningen, HOOFDSTUK BOEK -